Anti-Obesity Drugs and Bone Health: A Critical Review

Critical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and other weight loss agents affect bone density and fracture risk during weight loss.

Anastasilakis, Athanasios D et al.·Diabetes·2025·Preliminary EvidenceReview
RPEP-09936ReviewPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
N=N/A
Participants
People living with obesity using anti-obesity medications

What This Study Found

Critical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and other weight loss agents affect bone density and fracture risk during weight loss.

Key Numbers

No specific numerical outcomes reported; this is a qualitative review of existing evidence across multiple drug classes.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide evidence.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Evidence comparison?
  • ?Next steps?

Trust & Context

Key Stat:
Key finding Critical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and o
Evidence Grade:
Based on design.
Study Age:
Published in 2025.
Original Title:
The effects of anti-obesity medications on bone metabolism: A critical appraisal.
Published In:
Diabetes, obesity & metabolism, 27(9), 4674-4688 (2025)
Database ID:
RPEP-09936

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Critical review of anti-obesity medication effects on bone metabolism examines how GLP-1 drugs and other weight loss agents affect bone density and fracture risk during weight loss.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09936·https://rethinkpeptides.com/research/RPEP-09936

APA

Anastasilakis, Athanasios D; Paccou, Julien; Palermo, Andrea; Polyzos, Stergios A. (2025). The effects of anti-obesity medications on bone metabolism: A critical appraisal.. Diabetes, obesity & metabolism, 27(9), 4674-4688. https://doi.org/10.1111/dom.16541

MLA

Anastasilakis, Athanasios D, et al. "The effects of anti-obesity medications on bone metabolism: A critical appraisal.." Diabetes, 2025. https://doi.org/10.1111/dom.16541

RethinkPeptides

RethinkPeptides Research Database. "The effects of anti-obesity medications on bone metabolism: ..." RPEP-09936. Retrieved from https://rethinkpeptides.com/research/anastasilakis-2025-the-effects-of-antiobesity

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.